Unfortunately, I can't wait to come and. Yeah, well, again talking about the work in my oversight committee, we've led an investigation of the pharmacy benefit managers. We still have a long way to go to prevent PBM manipulation of patient access to effective and affordable medicines. I was glad to see the lower cost, more transparency act signed into law by President Trump. (02:07–02:14)
CLAIM
Asserts that there is ongoing work to prevent PBM manipulation of patient access to medicines.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
